Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.0240-0.0050 (-17.24%)
At close: 04:58PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 7.70M
Enterprise value 10.03M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.26
Price/book (mrq)N/A
Enterprise value/revenue 4.25
Enterprise value/EBITDA -2.59

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-85.50%
S&P500 52-week change 3-16.62%
52-week high 30.2300
52-week low 30.0230
50-day moving average 30.0474
200-day moving average 30.1055

Share statistics

Avg vol (3-month) 3168.4k
Avg vol (10-day) 3221.14k
Shares outstanding 5265.45M
Implied shares outstanding 6N/A
Float 8142.59M
% held by insiders 148.84%
% held by institutions 13.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin -216.11%
Operating margin (ttm)-211.34%

Management effectiveness

Return on assets (ttm)-27.93%
Return on equity (ttm)-199.94%

Income statement

Revenue (ttm)2.44M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)15.10%
Gross profit (ttm)498.12k
EBITDA -4.26M
Net income avi to common (ttm)-5.27M
Diluted EPS (ttm)-0.0230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.28M
Total cash per share (mrq)0
Total debt (mrq)3.61M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.65
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-4.25M
Levered free cash flow (ttm)-6.26M